The exact cause of adenoid cystic carcinoma is unknown. However, current research suggests that genetic changes (mutations) are the underlying basis of cellular malignant transformation in many cancers, including ACC.
What is the survival rate of adenoid cystic carcinoma?
The 5-year survival rate for people with AdCC is approximately 89%. The 15-year survival rate for people with AdCC is approximately 40%. A late recurrence of AdCC is common and can occur many years after initial treatment.
What are the symptoms of adenoid cystic carcinoma?
Adenoid Cystic Carcinoma: Symptoms and Signs
- A lump on the roof of the mouth, under the tongue, or in the bottom of the mouth.
- An abnormal area on the lining of the mouth.
- Numbness of the upper jaw, palate, face, or tongue.
- Difficulty swallowing.
- Hoarseness.
- Dull pain.
How common is adenoid cystic carcinoma?
Of the 500,000 people who get cancer each year, about 1,200 of them have adenoid cystic carcinoma. It affects more women than men, and it can happen at any age between your teens and your 80s. It tends to grow slowly, so it sometimes can spread to other parts of your body before you notice any symptoms.
Does adenoid cystic carcinoma spread?
Regardless of where it starts, AdCC tends to spread along nerves, known as a perineural invasion, or through the bloodstream. It spreads to the lymph nodes in about 5% to 10% of cases. If it spreads to another part of the body beyond the lymph nodes, it is called metastatic cancer.
Is Chemo Effective for adenoid cystic carcinoma?
Adenoid cystic carcinoma (ACC) is an aggressive malignant neoplasm of the secretory glands. Conventional chemotherapy has poor effectiveness against metastatic ACC. Thus, a novel effective therapy is needed against metastatic ACC. A majority of ACCs (up to 94%) express c-kit.
Who treats adenoid cystic carcinoma?
Often, a surgeon will be the first medical professional seen by an ACC patient, with later referrals to radiation oncologists, radiologists and/or medical oncologists. Radiation oncologists may treat tumors that cannot be removed surgically, residual disease after surgery or recurrences.